AACR 2020 Poster: QuANTUM-R Biomarker Encore Poster
American Association for Cancer Research
Scientific Publications
Peer-reviewed articles and conference poster presentations
All Scientific Literature Publications
-
Download Poster AACR 2020 Poster: QuANTUM-R Biomarker Encore Poster
-
Download Poster Selective Induction of Activated Treg Cells in Healthy Volunteers for the Treatment of Autoimmune Diseases
Selective Induction of Activated Treg Cells in Healthy Volunteers for the Treatment of Autoimmune Diseases
American College of Rheumatology -
Download Poster Development and technical validation of tetramer staining for use as a biomarker for assessing gluten-specific T cells in clinical studies
Development and technical validation of tetramer staining for use as a biomarker for assessing gluten-specific T cells in clinical studies
International Celiac Disease Symposium -
Download Poster Validation of a Gliadin α-I/α-II DQ2 Tetramer Flow Cytometric Assay a Biomarker to Asess Gluten Specific T Cells in Celiac Disease
Validation of a Gliadin α-I/α-II DQ2 Tetramer Flow Cytometric Assay a Biomarker to Asess Gluten Specific T Cells in Celiac Disease
Federation of Clinical Immunology Societies -
Download Poster Epigenetic assays for leukocyte subpopulations identification in sepsis cohort
Epigenetic assays for leukocyte subpopulations identification in sepsis cohort
International Symposium on Intensive Care and Emergency Medicine -
Download Poster Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci
Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci
United European Gastroenterology Week -
Download Poster Etirinotecan pegol Target-Specific Pharmacodynamic (PD) Biomarkers Measured in Circulating Tumor Cells (CTCs) from Patients in the Phase 3 BEACON Study in Patients with
%20Biomarkers%20Measured%20in%20Circulating%20Tumor%20Cells%20(CTCs)%20from%20Patients%20in%20the%20Phase%203%20BEACON%20Study%20in%20Patients%20with.jpg?width=612&height=283&name=108.%20Etirinotecan%20pegol%20Target-Specific%20Pharmacodynamic%20(PD)%20Biomarkers%20Measured%20in%20Circulating%20Tumor%20Cells%20(CTCs)%20from%20Patients%20in%20the%20Phase%203%20BEACON%20Study%20in%20Patients%20with.jpg)
Etirinotecan pegol Target-Specific Pharmacodynamic (PD) Biomarkers Measured in Circulating Tumor Cells (CTCs) from Patients in the Phase 3 BEACON Study in Patients with
American Society of Clinical Oncology -
Download Poster Characterization and Identification of Specific EGFR Mutations in Circulating Tumor Cells (CTCs) Isolated From Non-Small Cell Lung Cancer Patients Using an Antibody Independent Method, ApoStream®
Characterization and Identification of Specific EGFR Mutations in Circulating Tumor Cells (CTCs) Isolated From Non-Small Cell Lung Cancer Patients Using an Antibody Independent Method, ApoStream®
American Society of Clinical Oncology